14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $22.23 $23.98 Thursday, 25th Apr 2024 EXEL stock ended at $23.53. This is 0.759% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 1.65% from a day low at $23.36 to a day high of $23.74.
90 days $20.02 $24.07
52 weeks $18.08 $24.34

Historical Exelixis prices

Date Open High Low Close Volume
Jan 08, 2024 $20.36 $22.57 $19.21 $22.54 5 814 558
Jan 05, 2024 $23.50 $23.50 $23.10 $23.24 1 747 000
Jan 04, 2024 $23.74 $23.96 $23.58 $23.61 1 713 044
Jan 03, 2024 $23.85 $23.98 $23.56 $23.74 1 642 424
Jan 02, 2024 $23.89 $24.34 $23.80 $23.93 1 329 437
Dec 29, 2023 $24.10 $24.15 $23.96 $23.99 1 236 772
Dec 28, 2023 $24.05 $24.23 $23.98 $24.13 1 367 896
Dec 27, 2023 $24.00 $24.08 $23.94 $24.05 1 190 936
Dec 26, 2023 $24.00 $24.15 $23.93 $24.02 1 166 748
Dec 22, 2023 $23.60 $23.99 $23.60 $23.94 1 190 254
Dec 21, 2023 $23.41 $23.61 $23.24 $23.48 1 460 020
Dec 20, 2023 $23.76 $23.85 $23.18 $23.22 1 726 359
Dec 19, 2023 $23.51 $23.91 $23.45 $23.84 3 290 673
Dec 18, 2023 $23.50 $23.52 $23.30 $23.34 1 644 185
Dec 15, 2023 $23.35 $23.68 $23.16 $23.41 3 012 910
Dec 14, 2023 $23.56 $23.69 $23.01 $23.31 2 341 360
Dec 13, 2023 $22.85 $23.62 $22.85 $23.59 2 422 286
Dec 12, 2023 $22.07 $22.96 $22.03 $22.77 2 082 420
Dec 11, 2023 $22.00 $22.17 $21.94 $22.05 2 119 444
Dec 08, 2023 $21.97 $22.15 $21.81 $22.00 1 395 886
Dec 07, 2023 $21.91 $22.08 $21.72 $21.99 1 534 435
Dec 06, 2023 $21.91 $22.06 $21.61 $21.93 1 829 970
Dec 05, 2023 $22.33 $22.41 $21.86 $21.87 2 034 720
Dec 04, 2023 $21.84 $22.44 $21.81 $22.43 2 032 057
Dec 01, 2023 $21.83 $21.98 $21.63 $21.94 1 854 523
Click to get the best stock tips daily for free!

About Exelixis

Exelixis Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CA... EXEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT